title: Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?
authors.affiliation: Department of Internal Medicine/Endocrinology and Metabolism, Academic Medical Center, G4-211, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. c.e.hollak@amc.uva.nl
authors.forename: C E M
authors.initials: CE
authors.lastname: Hollak
authors.forename: G E
authors.initials: GE
authors.lastname: Linthorst
mesh_terms: D000795:Fabry Disease / Q000188:drug therapy* / Q000201:enzymology / Q000276:immunology*; D006801:Humans; D007527:Isoenzymes / Q000276:immunology / Q000627:therapeutic use*; D016896:Treatment Outcome; D000519:alpha-Galactosidase / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta